Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 μl per 10^6 cells in a 100 µl suspension or 5 μl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL405-65188 targets CD314/NKG2D in FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG1, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | NKL cell line Predict reactive species |
Full Name | killer cell lectin-like receptor subfamily K, member 1 |
Calculated Molecular Weight | 25 kDa |
GenBank Accession Number | BC039836 |
Gene Symbol | KLRK1 |
Gene ID (NCBI) | 22914 |
RRID | AB_3672391 |
Conjugate | CoraLite® Plus 405 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 399 nm / 422 nm |
Form | Liquid |
Purification Method | Affinity purification |
UNIPROT ID | P26718 |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
CD314, also known as NKG2D or Killer cell lectin-like receptor subfamily K member 1 (KLRK1), is a type II lectin-like transmembrane stimulatory receptor (PMID: 8436421). In humans, it is expressed on NK cells, gamma delta T cells, and CD8+ alpha beta T cells (PMID: 10426993). Various families of cell surface ligands have been identified, including the MICA/MICB and ULBP proteins (PMID: 12150888). CD314 is involved in both innate and adaptive immunities, and the NKG2D/NKG2DL pathway involves multiple effector cell types for controlling tumor progression (PMID: 31720075).
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CL Plus 405 CD314/NKG2D antibody CL405-65188 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |